+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Precision Medicine Partnering 2014-2019: Deal trends, players and financials

  • ID: 2300222
  • Report
  • Region: Global
  • 1000 Pages
  • CurrentPartnering
1 of 4

FEATURED COMPANIES

  • 1CellBiO
  • Alion Pharmaceuticals
  • Asthma UK
  • Biothera
  • CDx Diagnostics
  • COPD Foundation
  • MORE
The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding and unprecedented access to the Precision medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest Precision Medicine agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Precision Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Precision Medicine partnering deals.

The report presents financial deal term values for Precision Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Precision Medicine partnering field; both the leading deal values and most active Precision Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 900 online deal records of actual Precision Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Precision Medicine dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Precision Medicine dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Precision Medicine deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Precision Medicine dealmaking with a brief summary followed by a comprehensive listing of Precision Medicine deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Precision Medicine partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Precision Medicine partnering deals signed and announced since Jan 2014. The chapter is organized by specific Precision Medicine technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Precision Medicine partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Precision Medicine partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Precision Medicine technologies and products.

Key Benefits

Global Precision Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts provides the reader with the following key benefits:
  • In-depth understanding of Precision Medicine deal trends since 2014
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Precision Medicine agreements with numerous real life case studies
  • Detailed access to actual Precision Medicine contracts entered into by leading biopharma companies
  • Identify most active Precision Medicine dealmakers since 2014
  • Insight into terms included in a Precision Medicine partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Report Scope

Global Precision Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Precision Medicine trends and structure of deals entered into by leading companies worldwide.

Precision Medicine Partnering Terms and Agreements includes:
  • Trends in Precision Medicine dealmaking in the biopharma industry since 2014
  • Analysis of Precision Medicine deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life Precision Medicine deals
  • Access to Precision Medicine contract documents
  • Leading Precision Medicine deals by value since 2014
  • Most active Precision Medicine dealmakers since 2014
In Global Precision Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts, the available deals are listed by:
  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Precision Medicine Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 900 Precision Medicine deals.

Analyzing actual contract agreements allows assessment of the following:
  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How aresalesand payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 1CellBiO
  • Alion Pharmaceuticals
  • Asthma UK
  • Biothera
  • CDx Diagnostics
  • COPD Foundation
  • MORE
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Precision Medicine dealmaking
2.1. Introduction
2.2. Precision Medicine partnering over the years
2.3. Most active Precision Medicine dealmakers
2.4. Precision Medicine partnering by deal type
2.5. Precision Medicine partnering by therapy area
2.6. Deal terms for Precision Medicine partnering
2.6.1 Precision Medicine partnering headline values
2.6.2 Precision Medicine deal upfront payments
2.6.3 Precision Medicine deal milestone payments
2.6.4 Precision Medicine royalty rates

Chapter 3 - Leading Precision Medicine deals
3.1. Introduction
3.2. Top Precision Medicine deals by value

Chapter 4 - Most active Precision Medicine dealmakers
4.1. Introduction
4.2. Most active Precision Medicine dealmakers
4.3. Most active Precision Medicine partnering company profiles

Chapter 5 - Precision Medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision Medicine contracts dealmaking directory

Chapter 6 - Precision Medicine dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices
Appendix 1 - Precision Medicine deals by company A-Z
Appendix 2 - Precision Medicine deals by stage of development
  • Discovery
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Regulatory
  • Marketed
  • Formulation
Appendix 3 - Precision Medicine deals by deal type
  • Asset purchase
  • Assignment
  • Bigpharma outlicensing
  • Co-development
  • Collaborative R&D
  • Co-market
  • Co-promotion
  • CRADA
  • Development
  • Distribution
  • Equity purchase
  • Evaluation
  • Grant
  • Joint venture
  • Licensing
  • Manufacturing
  • Marketing
  • Option
  • Promotion
  • Research
  • Settlement
  • Spin out
  • Sub-license
  • Supply
  • Technology transfer
  • Termination
Appendix 4 - Precision Medicine deals by therapy area
Appendix 5 -Deal type definitions

List of Figures
Figure 1: Precision Medicine partnering since 2014
Figure 2: Active Precision Medicine dealmaking activity since 2014
Figure 3: Precision Medicine partnering by deal type since 2014
Figure 4: Precision Medicine partnering by disease type since 2014
Figure 5: Precision Medicine deals with a headline value
Figure 6: Precision Medicine deals with an upfront value
Figure 7: Precision Medicine deals with a milestone value
Figure 8: Precision Medicine deals with a royalty rate value
Figure 9: Top Precision Medicine deals by value since 2014
Figure 10: Most active Precision Medicine dealmakers since 2014
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 1CellBiO
  • 2bPrecise
  • 2X Oncology
  • 3D Systems
  • 4D Pharma
  • 20/20 GeneSystems
  • 23andMe
  • 48Hour Discovery
  • A*STAR Agency for Science
  • Technology and Research
  • A*STAR Bioinformatics Institute
  • A*STAR Bioprocessing Technology Institute
  • A*STAR Genome Institute of Singapore
  • Abbott Laboratories
  • Abbvie
  • Abcam
  • Abcodia
  • Abramson Cancer Center
  • Academic Medical Center
  • Accelerate Diagnostics
  • AccuGenomics
  • Accu Reference Medical Laboratory
  • AC Immune
  • Acumen Pharmaceuticals
  • Adaptive Biotechnologies
  • Adarza BioSystems
  • ADC Therapeutics
  • Admera Health
  • Aduro BioTech
  • Advanced Cell Diagnostics
  • Advanced Nuclear Medicine Ingredients
  • Advaxis
  • Aelan Cell Technologies
  • Aerocrine
  • Affigen
  • AFFiRiS
  • Affymetrix
  • Age Labs
  • Agendia
  • Agilent Technologies
  • Agios Pharmaceuticals
  • Air Force Research Laboratory
  • AIT Laboratories
  • Akers Biosciences
  • AKESOgen
  • Akili Interactive Labs
  • Albert Einstein College of Medicine
  • Alcyone Lifesciences
  • Alector
  • Alexion Pharmaceuticals
  • Alion Pharmaceuticals
  • Allele Biotechnology and Pharmaceuticals
  • AlloSource
  • Allscripts
  • Almac Diagnostics
  • Alpha Genomix Laboratories
  • ALS Association
  • ALS Finding a Cure Foundation
  • Altor BioScience
  • Alzeca Biosciences
  • Alzheimer's Association
  • Alzheimer's Drug Discovery Foundation
  • Alzheimers Research UK
  • Amarantus BioSciences
  • Amarna Therapeutics
  • Ambiopharm
  • American Association for Cancer Research
  • American Association of Neuromuscular & Electrodiagnostic Medicine
  • American Diabetes Association
  • AmerisourceBergen
  • Amgen
  • AmorChem
  • Amoy Diagnostics
  • AmpTec
  • AMRA
  • Analytics Engines
  • Anam Hospital
  • Anavex Life Sciences
  • Angle
  • Annoroad
  • Apocell
  • Apogenix
  • Appistry
  • Applied DNA Sciences
  • Arbor Biotechnologies
  • ArcherDX
  • ARCH Personalized Medicine Initiative
  • Arcis Biotechnology
  • Arcus Biosciences
  • Arcus Therapeutics
  • Arno Therapeutics
  • AroCell
  • Array Biopharma
  • Arrow Diagnostics
  • Artialis
  • Ascenion
  • Association for Frontotemporal Degeneration
  • Assurex Health
  • Assuta Medical Centers
  • Astellas Pharma
  • Asterand Bioscience
  • Asthma UK
  • AstraZeneca
  • Astute Medical
  • Asuragen
  • Auria Biobank
  • Aurigene Discovery Technologies
  • Australian Imaging
  • Biomarker & Lifestyle Flagship Study of Ageing (AIBL)
  • Austrian Institute of Technology
  • Autifony Therapeutics
  • AutoGenomics
  • AVEO Oncology
  • Avera Health
  • Avera Heart Hospital of South Dakota
  • Aviana Molecular Technologies
  • Avidity Biosciences
  • Ayasdi
  • AyoxxA Biosystems
  • Bank of America
  • Banyan Biomarkers
  • Baxter International
  • Bayer
  • Bayer Healthcare
  • Baylor College of Medicine
  • BC Platforms
  • BeiGene
  • Beijing Genomics Institute (BGI)
  • Berg
  • Bertin Pharma
  • Beth Israel Deaconess Medical Center
  • BGI
  • BGI Tech Solutions
  • Bill and Melinda Gates Foundation
  • Bio-Techne
  • BioArctic Neuroscience
  • Biocartis
  • Biocept
  • Biodesix
  • BioDiscovery
  • Biogen
  • Biognosys
  • Biohealth Innovation
  • BioMarker Strategies
  • Biomedical Advanced Research and Development Authority
  • Biomedical Catalyst Fund (UK)
  • bioMerieux
  • BiomX
  • BioNTech
  • BioPorto
  • Biopsy Sciences
  • BioReference Laboratories
  • BioRestorative Therapies
  • Biotest
  • Biothera
  • BioTheranostics
  • BioVendor
  • Bioyong
  • Bird Foundation
  • Blackfynn
  • BlackThorn Therapeutics
  • Blinktbi
  • Bliss Biopharmaceutical
  • Blue Cross Blue Shield Association
  • BluePen Biomarkers
  • Blueprint Medicines
  • Boehringer Ingelheim
  • Bonnie J. Addario Lung Cancer Foundation
  • Boston University School of Medicine
  • Bpifrance
  • Brain Biomarker Solutions in Gothenburg
  • BrainScope
  • Breath Diagnostics
  • Brigham and Women's Hospital
  • Bristol-Myers Squibb
  • Bristol-Myers Squibb Pakistan
  • Broad Institute
  • Brooks Automation
  • Brown University
  • Buck Institute for Age Research
  • BurstIQ
  • C2N Diagnostics
  • Cachet Pharma
  • Caladrius Biosciences
  • California Institute for Biomedical Research
  • California Institute for Regenerative Medicine
  • California Stem Cell
  • Cambia Health Solutions
  • Cambridge Epigenetix
  • Cambridge Isotope Laboratories
  • Canadian Cancer Society
  • Canadian Cancer Trials Group
  • Canadian Institutes of Health Research
  • Canadian National Transplant Research Program
  • CANbridge Life Sciences
  • Cancer Genetics
  • Cancer Immunotherapy Trials Network
  • Cancer Research Institute
  • Cancer Research Society
  • Cancer Research UK
  • Canopy Biosciences
  • Cantonal Hospital
  • Caprion Biosciences
  • Caprion Proteomics
  • CARB-X
  • Caris Life Sciences
  • Carlos Slim Health Institute
  • Carmentix
  • Carolina BioOncology Institute
  • Carolinas Medical Center (CMC)
  • Case Western Reserve University
  • CASI Pharmaceuticals
  • Catalan Institute of Nanotechnology (ICN)
  • Catalyn Medical Technologies
  • Catholic University Leuven
  • CBD Solutions
  • CBLPath
  • CDx Diagnostics
  • Cedars-Sinai Medical Center
  • Celgene
  • Cellgen Diagnostics
  • Cellnetix
  • Cell Signaling Technology
  • Celmatix
  • Celsee
  • Celsius Therapeutics
  • Cenix BioScience
  • Centene
  • Center for Biomarker Research in Medicine
  • Center for Human Immunology
  • Autoimmunity and Inflammation
  • Centers for Disease Control and Prevention
  • Centogene
  • Centre for Commercialization of Regenerative Medicine (CCRM)
  • Centre for Drug Research and Development (CDRD)
  • Centre for Imaging Technology Commercialization
  • Centre For Proteomic & Genomic Research
  • Centre Hospital University - Bordeaux
  • Centre Leon Berard
  • Centre National de la Recherche Scientifique
  • CerebraCell
  • Certainty Health
  • Certis
  • Cerveau Technologies
  • Chan Soon-Shiong Institute of Molecular Medicine
  • CHDI Foundation
  • Chek Diagnostics
  • Chembio Diagnostics
  • Children's Hospital Boston
  • Children's Hospital of Orange County
  • Children's Medical Research Institute
  • Children's Minnesota
  • Children's Research Institute
  • Children’s Hospital Colorado
  • Children’s Hospital Oakland Research Institute (CHORI)
  • Christian Doppler Research Association
  • Chugai Pharmaceutical
  • Cincinnati Children’s Hospital Medical Center
  • Circulogene
  • Citizens United for Research in Epilepsy
  • City of Hope
  • Clarient
  • Clearbridge Biomedics
  • Cleveland Clinic
  • Cleveland HeartLab
  • Clevexel Pharma
  • Clinical Genomics
  • Clinical Outcomes Tracking and Analysis
  • Clinica Ruiz
  • Cloudera
  • Cloud Pharmaceuticals
  • Clovis Oncology
  • Cognition Therapeutics
  • Cohen Veterans Bioscience
  • Color
  • Columbia University
  • Columbia University Medical Center
  • Combating Terrorism Technical Support Office
  • Companion Dx Reference Lab
  • CompanionDx Reference Lab
  • Companion Medical
  • Compugen
  • Concerto HealthAI
  • Contextual Genomics
  • COPD Foundation
  • Core Diagnostics India
  • Corgenix Medical
  • Coriell Life Sciences
  • Cornell University
  • Corning
  • Cosmo Bio
  • COTA
  • Courtagen Life Sciences
  • Covance
  • CRC Health
  • Critical Diagnostics
  • Crohn's and Colitis Foundation of America
  • Crossbeta Biosciences
  • Crown Bioscience
  • CSIRO
  • Cure Forward
  • CURE Pharmaceutical
  • Curetis
  • Curie-Cancer
  • Curis
  • CvergenX
  • Cyclica
  • Cypher Genomics
  • CytoLumina Technologies
  • Cytox
  • Daiichi Sankyo
  • Dako
  • DalCor Pharmaceuticals
  • Dana-Farber Cancer Institute
  • Danish Center for Strategic Research into Type 2 Diabetes
  • DarioHealth
  • Datavant
  • David H. Koch Institute for Integrative Cancer Research
  • Debiopharm
  • Defense Advanced Research Projects Agency
  • Definiens
  • Dell
  • Deloitte
  • Denovo Biopharma
  • Department of Defense
  • Department of Veterans Affairs
  • DestiNA Genomics
  • Devicor Medical Products
  • DiaCarta
  • Diaceutics
  • diaDexus
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll